IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis

J Immunol. 2005 Mar 1;174(5):2990-9. doi: 10.4049/jimmunol.174.5.2990.

Abstract

Nonpathogenic enteric bacterial species initiate and perpetuate experimental colitis in IL-10 gene-deficient mice (IL-10(-/-)). Bacteria-specific effects on the epithelium are difficult to dissect due to the complex nature of the gut microflora. We showed that IL-10(-/-) mice compared with wild-type mice fail to inhibit proinflammatory gene expression in native intestinal epithelial cells (IEC) after the colonization with colitogenic Gram-positive Enterococcus faecalis. Interestingly, proinflammatory gene expression was transient after 1 wk of E. faecalis monoassociation in IEC from wild-type mice, but persisted after 14 wk of bacterial colonization in IL-10(-/-) mice. Accordingly, wild-type IEC expressed phosphorylated NF-kappaB subunit RelA (p65) and phosphorylated Smad2 only at day 7 after bacterial colonization, whereas E. faecalis-monoassociated IL-10(-/-) mice triggered persistent RelA, but no Smad2 phosphorylation in IEC at days 3, 7, 14, and 28. Consistent with the induction of TLR2-mediated RelA phosphorylation and proinflammatory gene expression in E. faecalis-stimulated cell lines, TLR2 protein expression was absent after day 7 from E. faecalis-monoassociated wild-type mice, but persisted in IL-10(-/-) IEC. Of note, TGF-beta1-activated Smad signaling was associated with the loss of TLR2 protein expression and the inhibition of NF-kappaB-dependent gene expression in IEC lines. In conclusion, E. faecalis-monoassociated IL-10(-/-), but not wild-type mice lack protective TGF-beta/Smad signaling and fail to inhibit TLR2-mediated proinflammatory gene expression in the intestinal epithelium, suggesting a critical role for IL-10 and TGF-beta in maintaining normal epithelial cell homeostasis in the interplay with commensal enteric bacteria.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Line
  • Cells, Cultured
  • Colitis / genetics*
  • Colitis / immunology
  • Colitis / microbiology
  • DNA-Binding Proteins* / deficiency
  • DNA-Binding Proteins* / physiology
  • Enterococcus faecalis / growth & development
  • Enterococcus faecalis / immunology
  • Gene Expression Regulation* / genetics
  • Gene Expression Regulation* / immunology
  • Gram-Positive Bacterial Infections / genetics
  • Gram-Positive Bacterial Infections / immunology
  • Inflammation Mediators / antagonists & inhibitors*
  • Inflammation Mediators / metabolism
  • Interleukin-10 / biosynthesis
  • Interleukin-10 / deficiency*
  • Interleukin-10 / genetics
  • Intestinal Mucosa / cytology
  • Intestinal Mucosa / immunology*
  • Intestinal Mucosa / metabolism
  • Mice
  • Mice, Inbred C3H
  • Mice, Knockout
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism
  • NF-kappa B / physiology
  • Phosphorylation
  • Receptors, Cell Surface / biosynthesis
  • Receptors, Cell Surface / deficiency
  • Receptors, Cell Surface / physiology
  • Signal Transduction / genetics*
  • Signal Transduction / immunology
  • Smad Proteins
  • Toll-Like Receptor 2
  • Trans-Activators* / deficiency
  • Trans-Activators* / physiology
  • Transcription Factor RelA
  • Transforming Growth Factor beta* / deficiency
  • Transforming Growth Factor beta* / physiology
  • Transforming Growth Factor beta1

Substances

  • DNA-Binding Proteins
  • Inflammation Mediators
  • NF-kappa B
  • Receptors, Cell Surface
  • Smad Proteins
  • Tgfb1 protein, mouse
  • Tlr2 protein, mouse
  • Toll-Like Receptor 2
  • Trans-Activators
  • Transcription Factor RelA
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta1
  • Interleukin-10